Complete Response in Gastric Tumor After Imatinib Treatment
Author Information
Author(s): El Mesbahi Omar, Brahmi Sami Aziz, Akasbi Yousra, El Mrabet Fatima Zahra, Touyar Anas, Ossaden Abdelmalek, Znati Kaoutar, Maazaz Khalid, Amarti Affaf, Tizniti Siham, Taleb Khalid Ait, Ibrahimi Adil
Primary Institution: Hassan II University Hospital, Fez, Morocco
Hypothesis
Can imatinib mesylate lead to a complete pathological response in advanced gastrointestinal stromal tumors?
Conclusion
The patient achieved a complete pathological response after treatment with imatinib mesylate.
Supporting Evidence
- The patient had a pathological complete response after neoadjuvant treatment with imatinib mesylate.
- Imatinib mesylate is the standard treatment for advanced gastrointestinal stromal tumors.
- Complete response to imatinib is rare, making this case noteworthy.
Takeaway
A woman with a stomach tumor got better after taking a medicine called imatinib, which helped her body fight the tumor completely.
Methodology
The patient received six months of imatinib mesylate treatment followed by surgery.
Limitations
The molecular biology examination was not done, and the patient did not undergo FDG-PET due to its unavailability.
Participant Demographics
54-year-old Arab woman
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website